Evidence map›Paper›PMID 34192052›Full record

ArticleJournal of clinical and translational science2021

It should not require a pandemic to make community engagement in research leadership essential, not optional.

Kevin Grumbach, Linda B Cottler, Jen Brown, Monique LeSarre, Ricardo F Gonzalez-Fisher, Carla D Williams, J Lloyd Michener, Donald E Nease, Darius Tandon, Deepthi S Varma and 1 more

Abstract read
In one paragraph

Article in Journal of clinical and translational science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Frontiers in health services · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Kevin GrumbachDepartment of Family and Community Medicine and Clinical and Translational Science Institute, University of California, San Francisco, CA, USA.
Linda B CottlerDepartment of Epidemiology and Clinical and Translational Science Institute, University of Florida, Gainesville, FL, USA.ORCID https://orcid.org/0000-0001-5643-8536
Jen BrownAlliance for Research in Chicagoland Communities and Clinical and Translational Sciences Institute, Northwestern University, Evanston, IL, USA.
Monique LeSarreRafiki Coalition and African American Community Health Equity Council, San Francisco, CA, USA.
Ricardo F Gonzalez-FisherServicios de La Raza, Metropolitan State University of Denver, Denver, CO, USA.ORCID https://orcid.org/0000-0001-6987-4062
Carla D WilliamsGeorgetown-Howard University Center for Clinical and Translational Science, Washington, DC, USA.
J Lloyd MichenerDepartment of Family Medicine and Community Health, Duke School of Medicine, Durham, NC, USA.ORCID https://orcid.org/0000-0001-9002-2681
Donald E NeaseDepartment of Family Medicine and the Colorado Clinical and Translational Sciences Institute, University of Colorado - Anschutz Medical Campus, Aurora, CO, USA.ORCID https://orcid.org/0000-0001-8323-3720
Darius TandonDepartment of Medical Social Sciences and Center for Community Health, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Deepthi S VarmaDepartment of Epidemiology, University of Florida, Gainesville, FL, USA.
Milton EderDepartment of Family Medicine and Community Health, Clinical and Translational Science Institute, University of Minnesota, Minneapolis, MN, USA.ORCID https://orcid.org/0000-0002-4036-6491

Funding

Clinical and Translational Science InstituteUL1TR001872 · NCATS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI COLLARD, HAROLD R, JACOBY, VANESSA · 2016 to 2025
$112.1M
Northwestern University Clinical and Translational Science Institute (NUCATS)UL1TR001422 · NCATS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI D'AQUILA, RICHARD · 2015 to 2023
$56.8M
NIH Prior Approval Process ProfessionalUL1TR002535 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2018 to 2022
$51.1M
Maternal Morbidity and Mortality: Risk Factors, Early Detection and Personalized InterventionUL1TR001409 · NCATS · GEORGETOWN UNIVERSITY · PI GONDRE-LEWIS, MARJORIE C, MELLMAN, THOMAS A · 2015 to 2024
$37.8M
Sleep Disorders in Adults with Sickle Cell Disease: Frequency, Associations with Cardiovascular and Pain Indicators, and Responses to TreatmentU54MD007597 · NIMHD · HOWARD UNIVERSITY · PI BYRON D. FORD · 2019 to 2026
$37.7M
Using social networks to map and evaluate team science across CTSA hubsUL1TR001427 · NCATS · UNIVERSITY OF FLORIDA · PI MITCHELL, DUANE A. · 2015 to 2024
$37.2M
University of Minnesota Clinical and Translational Science Institute (UMN CTSI)UL1TR002494 · NCATS · UNIVERSITY OF MINNESOTA · PI BLAZAR, BRUCE R, WEISDORF, DANIEL J · 2018 to 2022
$34.9M
NCATS NIH HHS UL1 TR001409NCATS NIH HHS UL1 TR001422NCATS NIH HHS UL1 TR001427NCATS NIH HHS UL1 TR001872NCATS NIH HHS UL1 TR002494NCATS NIH HHS UL1 TR002535NIMHD NIH HHS U54 MD007597
6 · The paper itself

Abstract

Efforts to move community engagement in research from marginalized to mainstream include the NIH requiring community engagement programs in all Clinical and Translational Science Awards (CTSAs). However, the COVID-19 pandemic has exposed how little these efforts have changed the dominant culture of clinical research. When faced with the urgent need to generate knowledge about prevention and treatment of the novel coronavirus, researchers largely neglected to involve community stakeholders early in the research process. This failure cannot be divorced from the broader context of systemic racism in the US that has contributed to Black, Indigenous, and People of Color (BIPOC) communities bearing a disproportionate toll from COVID-19, being underrepresented in COVID-19 clinical trials, and expressing greater hesitancy about COVID-19 vaccination. We call on research funders and research institutions to take decisive action to make community engagement obligatory, not optional, in all clinical and translational research and to center BIPOC communities in this process. Recommended actions include funding agencies requiring all research proposals involving human participants to include a community engagement plan, providing adequate funding to support ongoing community engagement, including community stakeholders in agency governance and proposal reviews, promoting racial and ethnic diversity in the research workforce, and making a course in community engaged research a requirement for Masters of Clinical Research curricula.

Indexed as

Community engagementequitytranslational science

Identifiers

PMID34192052
PMCPMC8134899

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.